Abstract: A compound having the formula ##STR1## processes for preparing such a compound, intermediates used in the preparation thereof, and pharmaceutical compositions and a method for the treatment of depression and relief of anxiety employing the same.

Abstract: A compound of the formula ##STR1## or a pharmaceutically acceptable acid addition salt thereof, in which formula the group R.sup.0 is selected from the group consisting of hydrogen, chlorine, bromine, methyl, trifluoromethyl and methoxy.Pharmaceutical compositions containing these compounds are useful for treatment of depressive disorders.

Abstract: A method for alleviating alcoholism comprising administering to a host in need of treatment an effective amount of the compound 4-methyl-1-homopiperazinedithiocarboxylic acid or a salt thereof, and a pharmaceutical preparation for alleviation of alcoholism comprising said compound or salt as an active ingredient.

Abstract: Compounds having the general formula ##STR1## pharmaceutical preparations containing the compounds and use in the treatment of hypertension.

Abstract: A compound of the formula ##STR1## and pharmaceutically acceptable acid addition salts thereof, in which formula the group R.sup.o is trifluoromethyl.Pharmaceutical compositions containing these compounds are useful for treatment of depressive disorders.

Abstract: Compounds of the formula ##STR1## wherein R.sup.1 is a hydrogen atom, a methyl group or an ethyl group and R.sup.2 is a hydrogen atom, ##STR2## wherein n is 1 or 2, provided that R.sup.1 is a methyl or an ethyl group when R.sup.2 is a hydrogen atom; methods for the preparation thereof; intermediates useful for their preparation; pharmaceutical preparations containing at least one of these compounds; and the use thereof in the treatment of alcoholism.

Abstract: A compound of the formula ##STR1## and pharmaceutically acceptable acid addition salts thereof, in which formula the group R.sup.o is selected from hydrogen, chlorine, bromine, methyl, trifluoromethyl and methoxy.Pharmaceutical compositions containing these compounds are useful for treatment of depressive disorders.

Abstract: A compound of the formula ##STR1## and pharmaceutically acceptable acid addition salts thereof, in which R.sub.1 represents an alkyl group selected from n-propyl, i-propyl, n-butyl, i-butyl and sek.butyl, R.sub.2 and R.sub.3 are the same or different and represent an alkyl group selected from ethyl, n-propyl, and i-propyl, or R.sub.2 and R.sub.3 together with the nitrogen atom may form a pyrrolidine or piperidine ring, and n is 2 or 3. Pharmaceutical preparations containing these compounds are useful as local anesthetics.

Abstract: The present invention relates to a process for preparing a polymer which is suitable for being administered parenterally from a saccharide, a polyhydric alcohol and a polymerization agent and to the polymer prepared therefrom. The invention relates also to an iron preparation suitable for parenteral -- intramuscular and intravenous -- injection, to a process for the preparation of the iron preparation, and to the use of the injectable iron preparations in human and veterinary medicine.

Abstract: Compounds of the formula ##STR1## and pharmaceutically acceptable salts thereof; processes for their preparation; intermediates useful for their preparation; pharmaceutical preparations containing at least one of these compounds; and the use thereof as a tranquilizing or neuroleptic agent.

Abstract: Compounds having the general formula ##STR1## pharmaceutical preparations containing the compounds and use in the treatment of hypertension.

Abstract: Compounds having the general formula ##STR1## or pharmaceutically acceptable salts thereof, in which formula R.sup.1 and R.sup.2 are the same or different and each represents a hydrogen atom, a lower alkyl group or a halogen atom, R.sup.3 represents a lower alkyl group or a benzyl group, R.sup.4 represents a hydrogen atom, a lower alkyl group, a benzyl group or a CH.sub.2 CH.sub.2 CH.sub.2 -bridge connected to the phenyl ring in ortho-position relative to the N-substituent, R.sup.5 represents a hydrogen atom or a methyl group and R.sup.6 represents a lower alkyl group, provided that R.sup.1 and/or R.sup.2 represents a lower alkyl group or a halogen atom where R.sup.3 represents a methyl group, R.sup.4 represents a methyl group and R.sup.5 represents a hydrogen atom; methods for the preparation thereof; intermediates useful for their preparation; pharmaceutical preparations containing at least one of these compounds; and the use thereof in the treatment of depressive states and alleviating anxiety.

Abstract: Compounds having the general formula ##STR1## or pharmaceutically acceptable salts thereof, in which formula R.sup.1 and R.sup.2 are the same or different and each represents a hydrogen atom, a lower alkyl group or a halogen atom, R.sup.3 represents a lower alkyl group or a benzyl group, R.sup.4 represents a hydrogen atom, a lower alkyl group, a benzyl group or a CH.sub.2 CH.sub.2 CH.sub.2 --bridge connected to the phenyl ring in ortho-position relative to the N-substituent, R.sup.5 represents a hydrogen atom or a methyl group and R.sup.6 represents a lower alkyl group, provided that R.sup.1 and/or R.sup.2 represents a lower alkyl group or a halogen atom when R.sup.3 represents a methyl group, R.sup.4 represents a methyl group and R.sup.5 represents a hydrogen atom; methods for the preparation thereof; intermediates useful for their preparation; pharmaceutical preparations containing at least one of these compounds; and the use thereof in the treatment of depressive states and alleviating anxiety.

Abstract: New carbonate esters of penicillins, having the formula ##EQU1## wherein R.sup. 1 is substituted or unsubstituted alkyl, alkenyl, aryl, aryloxy or heterocyclic group, R.sup.2 is ##EQU2## in which formula R.sup.3 is H or -CH.sub.3,R.sup.4 is a substituted or unsubstituted alkyl, cycloalkyl, aryl, aralkyl or heterocyclic group, X is hydrogen, azido or hydroxy, n is 0 or 1, provided that X is hydroxy when n is 1 and R.sup.4 is an unsubstituted alkyl group and R.sup.1 is an alkyl, thienyl, furyl, phenyl or hydroxy-substituted phenyl group, useful as active ingredients of pharmaceutical preparations: processes for their preparation; and methods for the treatment of bacterial infections.

Abstract: A novel class of glycylglycine amides has been discovered having value as antiarrhythmic agents. The preferred compound of the present invention has the structural formula ##EQU1## Also included within the scope of this invention are compounds having C.sub.1 -C.sub.3 alkyl, alkoxy and halo substituents in the ortho, para or meta positions of the aromatic ring, compounds in which the phenyl group is replaced by benzyl or substituted benzyl and compounds in which the glycylglycine chain may be substituted with lower alkyl groups or may contain heterocyclic rings.

Abstract: An iron-containing composition suitable for parenteral administration in human and veterinary medicine consisting essentially of an aqueous solution of a complex of iron, said complex containing iron bound to a physiologically innocuous, water swellable polymer which is the reaction product ofI. at least one hydroxy carboxylic acid selected from the group consisting of arabonic acid, gluconic acid and glucoheptonic acid and salts and lactones derivable therefrom;Ii. at least one polyhydric alcohol selected from the class consisting of glycerol, polyglycerols, tetritols, pentitols, hexitols, heptitols, with alkyl groups containing from 1 to 5 carbon atoms partially etherified derivatives of said polyhydric alcohols, and with hydroxyalkyl groups containing from 1 to 5 carbon atoms partially etherified derivatives of said polyhydric alcohols; andIii. at least one polymerizing agent selected from the group consisting of dihalohydrins and epihalohydrins and diepoxides derivable therefrom, and mixtures thereof.

Abstract: An iron-containing composition suitable for parenteral administration in human and veterinary medicine consisting essentially of an aqueous solution of a complex of iron, said complex containing iron bound to a physiologically innocuous, water swellable polymer which is the reaction product ofI. at least one hydroxy carboxylic acid selected from the group consisting of arabonic acid, gluconic acid and glucoheptonic acid and salts and lactones derivable therefrom;Ii. at least one polyhydric alcohol selected from the class consisting of glycerol, polyglycerols, tetritols, pentitols, hexitols, heptitols, with alkyl groups containing from 1 to 5 carbon atoms, partially etherified derivatives of said polyhdydric alcohols, and with hydroxyalkyl groups containing from 1 to 5 carbon atoms partially etherified derivatives of said polyhydric alcohols; andIii. at least one polymerizing agent selected from the group consisting of dihalohydrins and epihalohydrins and diepoxides derivable therefrom, and mixtures thereof.

Abstract: Compounds having the general formula ##SPC1##Methods for the preparation thereof and use in the treatment of hypertension.

Abstract: New esters of .alpha.-aminopenicillins having the formula ##EQU1## wherein R is C.sub.2 -C.sub.7 alkyl; WHEREIN R.sup.2 = H or OH, R.sup.3 = H or halogen; ##SPC1##Wherein R.sup.1 is ##EQU2## or --Ch.sub.2 NHCOO--R.sup.4 wherein R.sup.4 = C.sub.1 -C.sub.4 alkyl; R.sup.5 = H, CH.sub.3 or C.sub.2 H.sub.5, useful as active ingredients of pharmaceutical preparation; processes for their preparation; chemical intermediates useful in said preparation; and methods for the treatment of infectious diseases.